New diabetes drugs available on Malta’s national health service

10% of the Maltese population suffers from diabetes • Gliptins and Repaglidine available on the NHS as from Monday

Two new diabetes drugs have been added to the national health service and will be available as from next Monday, parliamentary secretary for health Chris Fearne announced.

Gliptins and repaglidine are used by people who suffer from diabetes. They have been on the market for years but were only added recently to the government formulary list. This forms part of the national diabetes strategy launched in December.

It is estimated that 10% of the Malta population suffers from diabetes. 1,200 Maltese patients take gliptins.

More in Health